Immunization, Hib3 in Spain
Spain: Immunization, Hib3 was 94.0% in 2024. ▬ Flat
Immunization, Hib3 in Spain, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Spain is 94.0%, measured in 2024.
That represents a change of up 1.1% on the previous year and down 3.1% over ten years.
Over the whole period, immunization, hib3 in Spain peaked at 98.0% in 2003 and was at its lowest, 82.0%, in 1998.
Spain ranks 64th of 191 countries on this measure, in the middle of the range.
Immunization, Hib3 in Spain, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 82.0% | — |
| 1999 | 82.0% | +0.0% |
| 2000 | 92.0% | +12.2% |
| 2001 | 96.0% | +4.3% |
| 2002 | 97.0% | +1.0% |
| 2003 | 98.0% | +1.0% |
| 2004 | 97.0% | -1.0% |
| 2005 | 96.0% | -1.0% |
| 2006 | 98.0% | +2.1% |
| 2007 | 96.0% | -2.0% |
| 2008 | 97.0% | +1.0% |
| 2009 | 96.0% | -1.0% |
| 2010 | 97.0% | +1.0% |
| 2011 | 97.0% | +0.0% |
| 2012 | 96.0% | -1.0% |
| 2013 | 96.0% | +0.0% |
| 2014 | 97.0% | +1.0% |
| 2015 | 97.0% | +0.0% |
| 2016 | 97.0% | +0.0% |
| 2017 | 95.0% | -2.1% |
| 2018 | 96.0% | +1.1% |
| 2019 | 96.0% | +0.0% |
| 2020 | 98.0% | +2.1% |
| 2021 | 93.0% | -5.1% |
| 2022 | 95.0% | +2.2% |
| 2023 | 93.0% | -2.1% |
| 2024 | 94.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 82.0% | 82.0% | 82.0% | 2 |
| 2000s | 96.3% | 92.0% | 98.0% | 10 |
| 2010s | 96.4% | 95.0% | 97.0% | 10 |
| 2020s | 94.6% | 93.0% | 98.0% | 5 |
Countries ranked near Spain
- 64 Armenia 94.0% compare
- 64 Barbados 94.0% compare
- 64 Botswana 94.0% compare
- 64 Bulgaria 94.0% compare
- 64 Cyprus 94.0% compare
- 64 Fiji 94.0% compare
- 64 Iceland 94.0% compare
- 64 India 94.0% compare
- 64 Kiribati 94.0% compare
- 64 Poland 94.0% compare
- 64 Seychelles 94.0% compare
- 64 Tuvalu 94.0% compare
- 64 Uruguay 94.0% compare
More health data for Spain
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2629 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,290 deaths per 1,000 people (2090)
- Number of infants who die before age 1 108 deaths (2100)
- Population ages 30-34, female, annual growth rate -1.29 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0273 units per person (2025)
- Population ages 30-34, male, annual growth rate -1.1 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.028 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Spain?
- Immunization, hib3 in Spain was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Spain?
- The highest recorded value was 98.0% in 2003.
- What is the lowest immunization, hib3 recorded in Spain?
- The lowest recorded value was 82.0% in 1998.
- How does Spain rank for immunization, hib3?
- Spain ranks 64th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Spain?
- Over the last ten years it is down 3.1%. The long-run trend across the full record is flat.
- Where does this Spain data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.